Yarger Wealth Strategies LLC Has $1.07 Million Stock Position in Bath & Body Works, Inc. (NYSE:BBWI)

Yarger Wealth Strategies LLC increased its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 9.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,546 shares of the company’s stock after buying an additional 2,385 shares during the quarter. Yarger Wealth Strategies LLC’s holdings in Bath & Body Works were worth $1,068,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of BBWI. American Century Companies Inc. lifted its stake in shares of Bath & Body Works by 0.7% during the second quarter. American Century Companies Inc. now owns 255,612 shares of the company’s stock valued at $9,982,000 after acquiring an additional 1,831 shares during the period. DekaBank Deutsche Girozentrale grew its stake in shares of Bath & Body Works by 14.6% during the second quarter. DekaBank Deutsche Girozentrale now owns 36,429 shares of the company’s stock worth $1,414,000 after purchasing an additional 4,632 shares during the period. Federated Hermes Inc. grew its position in shares of Bath & Body Works by 275.1% during the 2nd quarter. Federated Hermes Inc. now owns 3,620 shares of the company’s stock worth $141,000 after buying an additional 2,655 shares during the period. Envestnet Asset Management Inc. increased its position in shares of Bath & Body Works by 5.7% in the 2nd quarter. Envestnet Asset Management Inc. now owns 140,300 shares of the company’s stock valued at $5,479,000 after buying an additional 7,611 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Bath & Body Works by 7.1% in the second quarter. Dimensional Fund Advisors LP now owns 1,303,487 shares of the company’s stock worth $50,901,000 after acquiring an additional 86,204 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. TD Cowen raised their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. JPMorgan Chase & Co. upped their price objective on Bath & Body Works from $35.00 to $39.00 and gave the company a “neutral” rating in a research note on Tuesday, November 26th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Morgan Stanley dropped their target price on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a report on Thursday, November 21st. Finally, Piper Sandler boosted their price target on Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a research note on Monday, January 6th. One research analyst has rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $43.06.

Bath & Body Works Price Performance

Shares of NYSE:BBWI opened at $36.63 on Friday. The company’s fifty day moving average price is $36.16 and its 200-day moving average price is $33.69. The firm has a market capitalization of $7.93 billion, a price-to-earnings ratio of 8.94, a PEG ratio of 0.98 and a beta of 1.82. Bath & Body Works, Inc. has a one year low of $26.20 and a one year high of $52.99.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same period in the previous year, the business earned $0.48 earnings per share. The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. As a group, equities research analysts expect that Bath & Body Works, Inc. will post 3.26 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were issued a dividend of $0.20 per share. The ex-dividend date was Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.18%. Bath & Body Works’s dividend payout ratio is 19.51%.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.